Uptake of the HPV vaccination programme in England: a cross-sectional survey of young women attending sexual health services
- 1Jefferiss Wing, Imperial College Healthcare NHS Trust, London, UK
- 2Research Department of Infection & Population Health, University College London, London, UK
- 3Camden Provider Services, Central and North West London NHS Foundation Trust, London, UK
- Correspondence to Dr Rachel J Sacks, Jefferiss Wing, St Mary's Hospital, Imperial College Healthcare NHS Trust, Praed Street, London, W2 1NY, UK;
- Received 24 April 2013
- Revised 30 August 2013
- Accepted 22 September 2013
- Published Online First 17 March 2014
Objectives The UK human papilloma virus (HPV) vaccination programme requires 80% uptake to have a significant impact on cervical cancer rates. Uptake in the first three years of the programme was 66%. We report the results of a cross-sectional survey of young women attending sexual health services (SHS) in England, reviewing HPV vaccination uptake and prevalence of HPV-related risk factors.
Methods An anonymous questionnaire surveyed women aged 13–19 attending 19 hospital-based and 13 community-based SHS across England, March–August 2011. Data were analysed using multiple logistic regression.
Results 2247 questionnaires were completed. Compared with national data, respondents had higher smoking rates (48% vs 14% of 15 year olds), coitarche under-16 (52% vs 38%), previous sexually transmitted infections (STIs) (25% vs 4%) and a higher proportion not in education, employment or training (NEETs) (8% vs 2% of 16 year olds).
Seventy-four per cent had been offered the vaccination, with significantly lower offer rates in London, non-white ethnicities, 17–19 year olds, NEETs, smokers and those with previous STIs (all p<0.05 in multivariate analysis). Sixty-five per cent of those offered, completed, with significantly lower completion rates in London, non-white ethnicities, 17–19 year olds, NEETs, smokers and those with previous STIs (all p<0.05 in multivariate analysis). Overall completion rate was 47%.
Conclusions We observed lower vaccination offer and completion rates and higher prevalence of HPV-related risk factors compared with national data. The highest risk individuals were the least likely to have been offered or to have completed the course. This survey highlights an opportunity for primary prevention by routinely offering the HPV vaccine to eligible women attending SHS.